These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 16382017

  • 1. Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.
    Boes E, Fliser D, Ritz E, König P, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Riegler P, Kronenberg F.
    J Am Soc Nephrol; 2006 Feb; 17(2):528-36. PubMed ID: 16382017
    [Abstract] [Full Text] [Related]

  • 2. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P.
    J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
    [Abstract] [Full Text] [Related]

  • 3. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
    Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F, MMKD Study Group.
    Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
    [Abstract] [Full Text] [Related]

  • 4. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes.
    Imbasciati E, Gregorini G, Cabiddu G, Gammaro L, Ambroso G, Del Giudice A, Ravani P.
    Am J Kidney Dis; 2007 Jun; 49(6):753-62. PubMed ID: 17533018
    [Abstract] [Full Text] [Related]

  • 5. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
    Kostapanos MS, Milionis HJ, Filippatos TD, Nakou ES, Bairaktari ET, Tselepis AD, Elisaf MS.
    Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
    [Abstract] [Full Text] [Related]

  • 6. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M, Collins D, Robins S, Bloomfield H, Curhan GC.
    Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949
    [Abstract] [Full Text] [Related]

  • 7. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD.
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [Abstract] [Full Text] [Related]

  • 8. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M, Kawar B, El Nahas AM.
    Nephron Clin Pract; 2009 May; 113(1):c16-23. PubMed ID: 19590231
    [Abstract] [Full Text] [Related]

  • 9. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 10. Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.
    Rule AD, Torres VE, Chapman AB, Grantham JJ, Guay-Woodford LM, Bae KT, Klahr S, Bennett WM, Meyers CM, Thompson PA, Miller JP, CRISP Consortium.
    J Am Soc Nephrol; 2006 Mar 20; 17(3):854-62. PubMed ID: 16452494
    [Abstract] [Full Text] [Related]

  • 11. Predictors of outcome in Henoch-Schönlein nephritis in children and adults.
    Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L.
    Am J Kidney Dis; 2006 Jun 20; 47(6):993-1003. PubMed ID: 16731294
    [Abstract] [Full Text] [Related]

  • 12. Dyslipidaemia as predictor of progressive renal failure and the impact of treatment with atorvastatin.
    Ozsoy RC, van der Steeg WA, Kastelein JJ, Arisz L, Koopman MG.
    Nephrol Dial Transplant; 2007 Jun 20; 22(6):1578-86. PubMed ID: 17347284
    [Abstract] [Full Text] [Related]

  • 13. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A, Djurdjev O, Beaulieu M, Er L.
    Am J Kidney Dis; 2008 Oct 20; 52(4):661-71. PubMed ID: 18805347
    [Abstract] [Full Text] [Related]

  • 14. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH, Karagiannis SE, Chonchol M, Vidakovic R, Noordzij PG, Elhendy A, van Domburg RT, Welten G, Schouten O, Bax JJ, Berl T, Poldermans D.
    J Am Soc Nephrol; 2007 Jun 20; 18(6):1872-9. PubMed ID: 17475817
    [Abstract] [Full Text] [Related]

  • 15. Influence of apolipoprotein E polymorphisms on serum creatinine levels and predicted glomerular filtration rate in healthy subjects.
    Liberopoulos EN, Miltiadous GA, Cariolou M, Kalaitzidis R, Siamopoulos KC, Elisaf MS.
    Nephrol Dial Transplant; 2004 Aug 20; 19(8):2006-12. PubMed ID: 15187200
    [Abstract] [Full Text] [Related]

  • 16. Serum lipid concentrations correlate with the progression of chronic renal failure.
    Yang WQ, Song NG, Ying SS, Liang HQ, Zhang YJ, Wei MJ, Wu KF.
    Clin Lab Sci; 1999 Aug 20; 12(2):104-8. PubMed ID: 10387487
    [Abstract] [Full Text] [Related]

  • 17. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG.
    Circulation; 2006 Jun 13; 113(23):2713-23. PubMed ID: 16754803
    [Abstract] [Full Text] [Related]

  • 18. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G, Targher G, Chonchol M, Perrone F, Lippi G, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2009 Oct 13; 19(8):580-6. PubMed ID: 19196499
    [Abstract] [Full Text] [Related]

  • 19. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease.
    O'Hare AM, Bertenthal D, Shlipak MG, Sen S, Chren MM.
    J Am Soc Nephrol; 2005 Feb 13; 16(2):514-9. PubMed ID: 15601746
    [Abstract] [Full Text] [Related]

  • 20. The relationship between apolipoprotein E polymorphism, lipoprotein (a) and fatty liver disease.
    Yang MH, Son HJ, Sung JD, Choi YH, Koh KC, Yoo BC, Paik SW.
    Hepatogastroenterology; 2005 Feb 13; 52(66):1832-5. PubMed ID: 16334787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.